{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:48:58Z","timestamp":1759942138012,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1023\/a:1012706630965","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T14:27:29Z","timestamp":1040653649000},"page":"315-321","source":"Crossref","is-referenced-by-count":9,"title":["Metabolic Management of Coronary Heart Disease: Adjunctive Treatment with Trimetazidine Decreases QT Dispersion in Patients with a First Acute Myocardial Infarction"],"prefix":"10.1007","volume":"15","author":[{"given":"Evaggelos","family":"Kountouris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Dimitroula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulos","family":"Karanikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Tzimas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Siogas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"382272_CR1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0735-1097(94)00446-W","volume":"25","author":"MR Zabel","year":"1995","unstructured":"Zabel MR, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study. J Am Coll Cardiol 1995; 25: 746-752.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"382272_CR2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","volume":"36","author":"M Malik","year":"2000","unstructured":"Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36(6): 1749-1766.","journal-title":"J Am Coll Cardiol"},{"key":"382272_CR3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/hrt.63.6.342","volume":"63","author":"CP Day","year":"1990","unstructured":"Day CP, McComb JM, Campbell RWF. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342-344.","journal-title":"Br Heart J"},{"key":"382272_CR4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0002-9149(92)90155-R","volume":"69","author":"NJ Linker","year":"1992","unstructured":"Linker NJ, Colonna P, Kekwick CA, Till J, Camm J, Ward DE. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992; 69: 634-638.","journal-title":"Am J Cardiol"},{"key":"382272_CR5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.CIR.86.5.1376","volume":"86","author":"JTY Hii","year":"1992","unstructured":"Hii JTY, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. PrecordialQTinterval dispersion as a marker of torsade de pointes: Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992; 86: 1376-1382.","journal-title":"Circulation"},{"issue":"1","key":"382272_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-5273(96)02732-5","volume":"57","author":"JM Glancy","year":"1996","unstructured":"Glancy JM, Garratt CJ, de Bono DP. Dynamics of QT dispersion during myocardial infarction and ischaemia. Int J Cardiol 1996; 57(1): 55-60.","journal-title":"Int J Cardiol"},{"issue":"12","key":"382272_CR7","first-page":"1438","volume":"29","author":"A Ciolli","year":"1999","unstructured":"Ciolli A, Di Lorenzo M, Bevilacqua U, et al. QT dispersion and early arrhythmic risk during acute myocardial infarction. G Ital Cardiol 1999; 29(12): 1438-1444.","journal-title":"G Ital Cardiol"},{"key":"382272_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0735-1097(95)00122-G","volume":"26","author":"JS Perkiomaki","year":"1995","unstructured":"Perkiomaki JS, Koistinen MJ, Yli Mayry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular arrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26: 174-179.","journal-title":"J Am Coll Cardiol"},{"key":"382272_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/01.CIR.90.1.94","volume":"90","author":"FLI Moreno","year":"1994","unstructured":"Moreno FLI, Teresa Villanueva Ma, Karagounis LA, Anderson JL, for the TEAM-2 Study Investigators. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. Circulation 1994; 90: 94-100.","journal-title":"Circulation"},{"issue":"6Pt.1","key":"382272_CR10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0002-8703(98)70068-7","volume":"135","author":"LA Karagounis","year":"1998","unstructured":"Karagounis LA, Anderson JL, Moreno FL, Sorensen SG. Multivariate associates of QT dispersion in patients with acute myocardial infarction: Primacy of patency status of the infarct-related artery. TEAM-3 Investigators. Third trial of thrombolysis with eminase in acute myocardial infarction. Am Heart J 1998; 135(6, Pt. 1): 1027-1035.","journal-title":"Am Heart J"},{"key":"382272_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00544569","volume":"33","author":"P Sellier","year":"1987","unstructured":"Sellier P, Audouin P, Payen B, Corona P, Duong TC, Ourbak P. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol 1987; 33: 205-207.","journal-title":"Eur J Clin Pharmacol"},{"key":"382272_CR12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/BF00143533","volume":"5","author":"Q Timour","year":"1991","unstructured":"Timour Q, Harpney C, Francoise D, Faucon C. Is the antianginal action of trimetazidine independent of hemodynamic changes. Cardiovasc Drugs Ther 1991; 5: 1043-1044.","journal-title":"Cardiovasc Drugs Ther"},{"key":"382272_CR13","doi-asserted-by":"crossref","first-page":"45B","DOI":"10.1016\/S0002-9149(99)80462-7","volume":"76","author":"L Kay","year":"1995","unstructured":"Kay L, Fineli C, Aussedat J, Guarnieri C, Rossi A. Improvement of long-term preservation of the isolated arrested rat heart by trimetazidine: Effects on the energy state and mitochondrial function. Am J Cardiol 1995; 76: 45B-49B.","journal-title":"Am J Cardiol"},{"key":"382272_CR14","first-page":"97","volume":"286","author":"N Lavanchy","year":"1987","unstructured":"Lavanchy N, Martin J, Rossi A. Anti-ischemia effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther 1987; 286: 97-110.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"382272_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2125.1985.tb05047.x","volume":"20","author":"I Maridonneau-Parini","year":"1985","unstructured":"Maridonneau-Parini I, Harpey C. Effects of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol 1985; 20: 148-151.","journal-title":"Br J Clin Pharmacol"},{"key":"382272_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/oxfordjournals.eurheartj.a015106","volume":"18","author":"N Meneveau","year":"1997","unstructured":"Meneveau N, Khalife K, Louis JP, et al. Free radicals, thrombolytic therapy and myocardial infarction: Results of the EMIP-FR angiography substudy. Eur Heart J 1997; 18: 171.","journal-title":"Eur Heart J"},{"issue":"2","key":"382272_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1007740311072","volume":"13","author":"R Ozdemir","year":"1999","unstructured":"Ozdemir R, Tuncer C, Aladag M, et al. Effect of trimetazidine on late potentials after acute myocardial infarction. Cardiovasc Drugs Ther 1999; 13(2): 145-149.","journal-title":"Cardiovasc Drugs Ther"},{"key":"382272_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5273(96)02678-2","volume":"55","author":"CL Papadopoulos","year":"1996","unstructured":"Papadopoulos CL, Kanonidis IE, Kotridis PS, et al. The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarction. Int J Cardiol 1996; 55: 137-142.","journal-title":"Int J Cardiol"},{"key":"382272_CR19","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1053\/euhj.1999.2439","volume":"21","author":"The EMIP-FR group.","year":"2000","unstructured":"The EMIP-FR group. Effect of 48-h intravenous trimetazidine on short-and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy. A double-blind, placebo-controlled, randomized trial. European Heart Journal 2000; 21: 1537-1546.","journal-title":"European Heart Journal"},{"issue":"5","key":"382272_CR20","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0735-1097(00)00921-9","volume":"36","author":"M Zabel","year":"2000","unstructured":"Zabel M, Franz MR, Klingenheben T, et al. Ratedependence of QT dispersion and the QT interval: Comparison of atrial pacing and exercise testing. Journal of the American College of Cardiology 2000; 36(5): 1654-1658.","journal-title":"Journal of the American College of Cardiology"},{"key":"382272_CR21","first-page":"353","volume":"7","author":"HC. Bazett","year":"1920","unstructured":"Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353-370.","journal-title":"Heart"},{"key":"382272_CR22","first-page":"543","volume":"12","author":"S Allibardi","year":"1998","unstructured":"Allibardi S, Chierchia SL, Cerioli V, et al. Trimetazidine reduces post-ischemic dysfunction in rat hearts by decreasing energy requirements during underperfusion. J Cardiovasc Pharmacol 1998; 12: 543-549.","journal-title":"J Cardiovasc Pharmacol"},{"key":"382272_CR23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00005344-199312000-00008","volume":"22","author":"FM Williams","year":"1993","unstructured":"Williams FM, Tanda K, Kus M, Williams TJ. Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits. J Cardiovasc Pharmacol 1993; 22: 828-833.","journal-title":"J Cardiovasc Pharmacol"},{"key":"382272_CR24","doi-asserted-by":"crossref","first-page":"41B","DOI":"10.1016\/S0002-9149(99)80461-5","volume":"76","author":"MI Noble","year":"1995","unstructured":"Noble MI, Belcher PR, Drake-Holland AJ. Limitation of infarct size by trimetazidine in the rabbit. Am J Cardiol 1995; 76: 41B-44B.","journal-title":"Am J Cardiol"},{"key":"382272_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1476-5381.1996.tb15268.x","volume":"117","author":"D Lagadic-Gossman","year":"1996","unstructured":"Lagadic-Gossman D, Le Prigent K, Feuvray D. Effect of trimetazidine on pHI regulation in the rat isolated ventricular myocytes. Br J Pharmacol 1996; 117: 831-837.","journal-title":"Br J Pharmacol"},{"key":"382272_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1472-8206.1997.tb00205.x","volume":"11","author":"E Fantini","year":"1997","unstructured":"Fantini E, Athias P, Demaison L, Grynberg A. Protective effects of trimetazidine on pHi regulation in hypoxic cardiac myocytes from the rat. Fundam Clin Pharmacol 1997; 11: 427-439.","journal-title":"Fundam Clin Pharmacol"},{"key":"382272_CR27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","volume":"86","author":"PF Kantor","year":"2000","unstructured":"Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86: 580-588.","journal-title":"Circ Res"},{"key":"382272_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00878324","volume":"7","author":"PR Belcher","year":"1993","unstructured":"Belcher PR, Drake-Holland AJ, Hynd JW, Noble MI. Effects of trimetazidine on in vivo coronary arterial platelet thrombosis. Cardiovasc Drugs Ther 1993; 7: 149-157.","journal-title":"Cardiovasc Drugs Ther"},{"key":"382272_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0008-6363(97)00221-6","volume":"37","author":"D Stilli","year":"1998","unstructured":"Stilli D, Aimi B, Sgoifo A, et al. Dependence of temporal variability of ventricular recovery on myocardial fibrosis. Role of mechanoelectrical feedback? Cardiovasc Res 1998; 37: 58-65.","journal-title":"Cardiovasc Res"},{"key":"382272_CR30","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0002-9149(97)00745-5","volume":"80","author":"M Naka","year":"1997","unstructured":"Naka M, Shiotani I, Koretsune Y, et al. Occurrence of sustained increase in QT dispersion following exercise in patients with residual myocardial ischemia after healing of anterior wall myocardial infarction. Am J Cardiol 1997; 80: 1528-1531.","journal-title":"Am J Cardiol"},{"key":"382272_CR31","first-page":"H1450","volume":"256","author":"RB Kleiman","year":"1989","unstructured":"Kleiman RB, Houser SR. Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 1989; 256: H1450-H1461.","journal-title":"Am J Physiol"},{"key":"382272_CR32","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0002-9149(97)00136-7","volume":"79","author":"A Yunus","year":"1997","unstructured":"Yunus A, Gillis AM, Traboulsi M, et al. Effect of coronary angioplasty on precordial QT dispersion. AmJ Cardiol 1997; 79: 1339-1342.","journal-title":"AmJ Cardiol"},{"key":"382272_CR33","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0002-9149(99)00050-8","volume":"83","author":"H Teragawa","year":"1999","unstructured":"Teragawa H, Hirao H, Muraoka Y, Yamagata T, Matsuura H, Kajiyama G. Relation between QT dispersion and adenosine triphosphate stress thallium-201 single-photon emission computed tomographic imaging for detecting myocardial ischemia and scar. Am J Cardiol 1999; 83: 1152-1156.","journal-title":"Am J Cardiol"},{"issue":"5A","key":"382272_CR34","doi-asserted-by":"crossref","first-page":"50K","DOI":"10.1016\/S0002-9149(98)00537-2","volume":"82","author":"A Desideri","year":"1998","unstructured":"Desideri A, Celegon L. Metabolic management of ischemic heart disease: Clinical data with trimetazidine. AmJ Cardiol 1998; 82(5A): 50K-53K.","journal-title":"AmJ Cardiol"},{"key":"382272_CR35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1994.tb04276.x","volume":"37","author":"JM Detry","year":"1994","unstructured":"Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine: A new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol 1994; 37: 279-288.","journal-title":"Br J Clin Pharmacol"},{"key":"382272_CR36","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/S0002-9149(99)80455-X","volume":"76","author":"JM Detry","year":"1995","unstructured":"Detry JM, Leclercq PJ. Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: Contribution of Holter electrocardiographic ambulatory monitoring. Am J Cardiol 1995; 76: 8B-11B.","journal-title":"Am J Cardiol"},{"issue":"Suppl4","key":"382272_CR37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/BF00051286","volume":"4","author":"P. Sellier","year":"1990","unstructured":"Sellier P. Chronic effects of trimetazidine on ergometric parameters in effort angina. Cardiovasc Drugs Ther 1990; 4(Suppl 4): 822-823.","journal-title":"Cardiovasc Drugs Ther"},{"key":"382272_CR38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/oxfordjournals.eurheartj.a060322","volume":"13","author":"G Kober","year":"1992","unstructured":"Kober G, Buck T, Sievert H, Vallbracht C. Myocardial protection during percutaneous transluminal coronary angioplasty: Effects of trimetazidine. Eur Heart J 1992; 13: 1109-1115.","journal-title":"Eur Heart J"},{"key":"382272_CR39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0002-9149(94)90462-6","volume":"74","author":"A Van de Loo","year":"1994","unstructured":"Van de Loo A, Arendts W, Hohnloser S. Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 1994; 74: 1113-1118.","journal-title":"Am J Cardiol"},{"key":"382272_CR40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(95)90697-5","volume":"345","author":"JM Glancy","year":"1995","unstructured":"Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945-948.","journal-title":"Lancet"},{"key":"382272_CR41","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.97.25.2543","volume":"97","author":"M Zabel","year":"1998","unstructured":"Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: Results of a prospective, long-term follow-up study. Circulation 1998; 97: 2543-2550.","journal-title":"Circulation"},{"key":"382272_CR42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-5273(98)00348-9","volume":"68","author":"RF Pedretti","year":"1999","unstructured":"Pedretti RF, Catalano O, Ballardini L, de Bono DP, Radice E, Tramarine R. Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion. Int J Cardiol 1999; 68: 83-93.","journal-title":"Int J Cardiol"},{"issue":"`9","key":"382272_CR43","first-page":"381","volume":"35","author":"D Puljevic","year":"1997","unstructured":"Puljevic D, Smalcelj A, Durakovic Z, Goldner V. The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction. Int J Clin Pharmacol Ther 1997; 35`(9): 381-384.","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012706630965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1012706630965\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012706630965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:20:39Z","timestamp":1751052039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1012706630965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["382272"],"URL":"https:\/\/doi.org\/10.1023\/a:1012706630965","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}